Reverb Therapeutics
Reverb Therapeutics is developing the Amplify•R™ platform, which uses bispecific antibody engineering to modulate the actions of endogenous cytokines for treating life-threatening diseases. Their initial focus is on treating cancer and autoimmune diseases by redirecting cytokines to tissues of interest and expanding their therapeutic potential.
Funding Round: Seed
Funding Amount: $12M
Date: 19-Feb-2025
Investors: Amplitude Ventures, Myeloma Investment Fund, KdT Ventures, Finchley Healthcare Ventures, InBC Investment Corp., Seido Capital
Markets: Biotech, Therapeutics, Healthcare
HQ: Vancouver, British Columbia, Canada
Founded: 2023
Website: https://www.reverbtx.com/
LinkedIn: https://www.linkedin.com/company/reverbtx
Crunchbase: https://www.crunchbase.com/organization/reverb-therapeutics
Leave a Comment
Comments
No comments yet.